Just over a week ago, a coronavirus variant first identified in January in Colombia has entered the list of mutations in Sars-CoV-2 under monitoring by the World Health Organization (WHO).
The Mu variant (or B.1.621) has come to be considered a “variant of interest” by the WHO, as it has “a constellation of mutations that indicate potential properties of escape from immunity”, that is, from the protection of vaccines – which is still needed confirmed by further studies, according to the organization’s bulletin released on Aug. 31.
Mu is, for the time being, a “variant of interest” being monitored by the WHO – the variants Alpha, Beta, Gamma (the one identified in Brazil) and Delta are considered “variants of concern”.
“Since it was identified in Colombia in January 2021, there have been some sporadic records of Mu variant cases and some larger outbreaks have been reported in other countries in South America and Europe,” says the WHO bulletin.
For now, the intergovernmental agency continues, the prevalence of Mu is less than 0.1% among sequenced cases of coronavirus worldwide.
But locally, its prevalence has “constantly increased” in Colombia and Ecuador, where it accounts for – respectively – 39% and 13% of cases sequenced. These data, however, should be read with caution, says the WHO, since most countries in the world have a low capacity to monitor the genetic sequencing of covid-19 variants.
It is currently estimated that Mu circulates in more than 40 countries, including Brazil – there are already confirmed case reports around here.
But, according to the open platform Gisaid, which compiles viral genomic data, Mu represents 0% of cases sequenced in Brazil. The platform has calculated that, so far, there are ten identified cases of Mu out of a total of nearly 35,000 sequenced, that is, cases in which the virus had its genomic analysis performed.
In Mexico, Mu represents 1% of the cases sequenced. In the US, 0%, but in absolute numbers, more than 1,700 cases of Mu sequence were detected.
In Colombia, health authorities have told the local press that Mu is already the predominant variant in circulation in the country, which so far has less than a third of its population vaccinated against the virus.
The third wave of covid-19 in the South American country, between April and June, has been attributed to this variant.
During this period, when Colombia registered around 700 deaths a day, nearly two-thirds of genetic tests carried out on fatal victims indicated the presence of the Mu variant, Marcela Mercado, research director at the Institute, told local radio on Sept. 2 National Health.
Delta still focuses concerns
The Colombian institute pointed out that the Mu variant has been shown to have a great transmission capacity.
It is important to highlight that the emergence of variants is expected within the advance cycle of a virus during a pandemic like the current one, especially in places where the circulation of this virus is still high. Most mutations have little or no effect on the virus’s properties.
But, in this process, some more dangerous variants emerge – and so far Delta is the one that raises the most concern in the world, having demonstrated a great transmission capacity and having been identified in about 170 countries.
In the State of Rio de Janeiro, for example, Delta is considered the predominant variant since mid-August.
What is alarming is the fact that Delta has advanced even in countries that already have high vaccination coverage. This does not mean, however, that this vaccine coverage has no effect, quite the contrary: the more people vaccinated with two doses (or with a single dose vaccine), the less chance that variants will emerge and find ground to proliferate.
What stands out in the Mu variant
O’Neill explained that, according to studies still in the pre-print phase (and therefore still needing scrutiny by the scientific community), Mu has a mutation called P681H, similar to that seen in the British variant Alpha and potentially making it more transmissible . “(But) we can’t be sure of the effects of P681H on virus behavior so far,” wrote O’Neill.
Other Mu mutations are also associated with an increased ability to evade antibodies created against the coronavirus, the researcher continued. In this case, the evidence appears to be more robust. “These mutations also occur in the Beta variant, and it is possible that the Mu behaves like the Beta, against which some vaccines are less efficient”, he detailed.
O’Neill reinforced the WHO conclusion that the Mu variant still needs further study, so that we can better understand its behavior and therefore its danger. “The epidemiology of Mu in South America, particularly with Delta’s co-circulation, will be monitored,” wrote WHO in its newsletter.
As of 29 August, the WHO said, there were more than 4,500 confirmed genomic analyzes of the Mu variant around the world, identified in the previous four weeks and counted by the Gisaid platform.
Have watched our new videos on YouTube? Subscribe to our channel!